Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellum | 3 | 2021 | 94 | 1.720 |
Why?
|
| Dementia | 13 | 2024 | 247 | 1.460 |
Why?
|
| Synapses | 2 | 2021 | 177 | 1.150 |
Why?
|
| Locomotion | 3 | 2018 | 108 | 1.120 |
Why?
|
| Behavior, Animal | 5 | 2018 | 214 | 1.030 |
Why?
|
| Hypothalamus | 2 | 2016 | 120 | 1.020 |
Why?
|
| Monitoring, Ambulatory | 3 | 2017 | 56 | 0.950 |
Why?
|
| Circadian Rhythm | 2 | 2018 | 370 | 0.900 |
Why?
|
| Cell Phone | 3 | 2013 | 43 | 0.840 |
Why?
|
| Gait Ataxia | 1 | 2021 | 3 | 0.770 |
Why?
|
| Complement C3 | 1 | 2021 | 61 | 0.750 |
Why?
|
| Caregivers | 6 | 2024 | 216 | 0.680 |
Why?
|
| Mice, Inbred C57BL | 12 | 2021 | 3193 | 0.650 |
Why?
|
| Walking | 2 | 2012 | 229 | 0.650 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 421 | 0.640 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 3 | 2015 | 7 | 0.620 |
Why?
|
| Galectin 3 | 1 | 2018 | 9 | 0.610 |
Why?
|
| Motor Activity | 6 | 2016 | 342 | 0.580 |
Why?
|
| Aging | 3 | 2023 | 723 | 0.570 |
Why?
|
| Excitatory Amino Acids | 1 | 2016 | 1 | 0.550 |
Why?
|
| Independent Living | 3 | 2022 | 45 | 0.550 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2017 | 37 | 0.540 |
Why?
|
| Activities of Daily Living | 3 | 2017 | 298 | 0.540 |
Why?
|
| Vocalization, Animal | 1 | 2015 | 4 | 0.520 |
Why?
|
| Reflex, Startle | 1 | 2015 | 6 | 0.520 |
Why?
|
| Feeding Behavior | 3 | 2017 | 314 | 0.510 |
Why?
|
| Immunomagnetic Separation | 1 | 2015 | 8 | 0.510 |
Why?
|
| Receptors, Serotonin | 3 | 2006 | 17 | 0.500 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 150 | 0.500 |
Why?
|
| Fear | 1 | 2015 | 64 | 0.500 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 98 | 0.480 |
Why?
|
| Mice | 17 | 2023 | 10260 | 0.470 |
Why?
|
| Phenotype | 2 | 2023 | 1157 | 0.470 |
Why?
|
| Behavior | 1 | 2014 | 38 | 0.450 |
Why?
|
| Wireless Technology | 1 | 2014 | 18 | 0.450 |
Why?
|
| Ecosystem | 2 | 2023 | 39 | 0.440 |
Why?
|
| Flow Cytometry | 1 | 2015 | 671 | 0.430 |
Why?
|
| Animals | 19 | 2023 | 19618 | 0.410 |
Why?
|
| Microglia | 1 | 2015 | 227 | 0.400 |
Why?
|
| Photometry | 1 | 2012 | 7 | 0.400 |
Why?
|
| Housing, Animal | 1 | 2012 | 14 | 0.390 |
Why?
|
| Mice, Knockout | 6 | 2021 | 1988 | 0.390 |
Why?
|
| Actigraphy | 1 | 2012 | 47 | 0.380 |
Why?
|
| Gait | 1 | 2012 | 114 | 0.360 |
Why?
|
| Exercise Test | 1 | 2012 | 233 | 0.350 |
Why?
|
| Medicare | 4 | 2023 | 601 | 0.340 |
Why?
|
| Stereotyped Behavior | 2 | 2009 | 10 | 0.320 |
Why?
|
| Software | 1 | 2012 | 367 | 0.320 |
Why?
|
| Central Nervous System Stimulants | 2 | 2007 | 63 | 0.300 |
Why?
|
| Piperazines | 2 | 2009 | 96 | 0.300 |
Why?
|
| Dextroamphetamine | 1 | 2007 | 3 | 0.300 |
Why?
|
| Male | 20 | 2024 | 27526 | 0.270 |
Why?
|
| Gene Targeting | 1 | 2006 | 82 | 0.250 |
Why?
|
| Ethanol | 2 | 2023 | 307 | 0.250 |
Why?
|
| Quality of Life | 2 | 2024 | 1109 | 0.250 |
Why?
|
| Dopamine | 3 | 2012 | 101 | 0.240 |
Why?
|
| Gene Deletion | 1 | 2006 | 298 | 0.230 |
Why?
|
| Cerebral Cortex | 3 | 2012 | 253 | 0.230 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2023 | 4 | 0.220 |
Why?
|
| Aged | 17 | 2024 | 13308 | 0.220 |
Why?
|
| Love | 1 | 2023 | 3 | 0.210 |
Why?
|
| Female | 19 | 2024 | 30845 | 0.210 |
Why?
|
| Potentially Inappropriate Medication List | 1 | 2022 | 14 | 0.210 |
Why?
|
| Alzheimer Disease | 5 | 2017 | 550 | 0.200 |
Why?
|
| Self Efficacy | 2 | 2024 | 201 | 0.200 |
Why?
|
| Inappropriate Prescribing | 1 | 2022 | 67 | 0.200 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2103 | 0.200 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 26 | 0.190 |
Why?
|
| Calorimetry, Indirect | 1 | 2021 | 32 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 164 | 0.190 |
Why?
|
| Health Care Costs | 2 | 2023 | 200 | 0.190 |
Why?
|
| Hand Strength | 1 | 2021 | 27 | 0.190 |
Why?
|
| Body Composition | 1 | 2021 | 154 | 0.180 |
Why?
|
| Catenins | 1 | 2020 | 9 | 0.180 |
Why?
|
| Energy Metabolism | 3 | 2016 | 349 | 0.170 |
Why?
|
| Point Mutation | 1 | 2000 | 162 | 0.170 |
Why?
|
| Humans | 25 | 2024 | 59350 | 0.170 |
Why?
|
| Nebraska | 3 | 2019 | 8 | 0.170 |
Why?
|
| Brain | 4 | 2014 | 1489 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 351 | 0.170 |
Why?
|
| Health Services for the Aged | 1 | 2019 | 48 | 0.160 |
Why?
|
| Middle Aged | 12 | 2024 | 16254 | 0.160 |
Why?
|
| Knee Joint | 1 | 2021 | 283 | 0.160 |
Why?
|
| Fee-for-Service Plans | 1 | 2019 | 67 | 0.160 |
Why?
|
| Patient Navigation | 1 | 2019 | 35 | 0.150 |
Why?
|
| Delivery of Health Care | 2 | 2019 | 421 | 0.150 |
Why?
|
| Health Expenditures | 1 | 2019 | 115 | 0.150 |
Why?
|
| Calcium | 1 | 2021 | 555 | 0.150 |
Why?
|
| Autophagy | 1 | 2020 | 205 | 0.150 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 172 | 0.150 |
Why?
|
| Drinking | 1 | 2017 | 14 | 0.140 |
Why?
|
| Apoptosis | 2 | 2021 | 1038 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 2 | 2016 | 880 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2020 | 509 | 0.140 |
Why?
|
| HIV Infections | 2 | 2014 | 919 | 0.140 |
Why?
|
| Cognition | 1 | 2000 | 459 | 0.140 |
Why?
|
| Raclopride | 1 | 2015 | 2 | 0.130 |
Why?
|
| Ultrasonics | 1 | 2015 | 16 | 0.130 |
Why?
|
| Dopamine Antagonists | 1 | 2015 | 15 | 0.130 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 22 | 0.130 |
Why?
|
| Program Development | 1 | 2017 | 210 | 0.130 |
Why?
|
| Aged, 80 and over | 7 | 2024 | 5071 | 0.130 |
Why?
|
| Suspensions | 1 | 2015 | 9 | 0.130 |
Why?
|
| Algorithms | 2 | 2014 | 986 | 0.130 |
Why?
|
| Cell Separation | 1 | 2015 | 149 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 810 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 192 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2014 | 44 | 0.120 |
Why?
|
| Telemedicine | 2 | 2017 | 335 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1537 | 0.120 |
Why?
|
| Mucociliary Clearance | 1 | 2014 | 6 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2014 | 12 | 0.110 |
Why?
|
| Axons | 1 | 2014 | 120 | 0.110 |
Why?
|
| Lasers | 1 | 2014 | 33 | 0.110 |
Why?
|
| Calibration | 1 | 2014 | 65 | 0.110 |
Why?
|
| Probability | 1 | 2014 | 172 | 0.110 |
Why?
|
| Remote Sensing Technology | 1 | 2013 | 5 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 2065 | 0.110 |
Why?
|
| Gene Expression | 1 | 2016 | 808 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2014 | 217 | 0.110 |
Why?
|
| Movement | 1 | 2014 | 146 | 0.100 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2012 | 6 | 0.100 |
Why?
|
| Neurons | 2 | 2009 | 858 | 0.100 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 73 | 0.100 |
Why?
|
| Single-Blind Method | 2 | 2023 | 134 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2013 | 262 | 0.100 |
Why?
|
| Pneumonia | 1 | 2014 | 263 | 0.090 |
Why?
|
| Equipment Design | 1 | 2012 | 314 | 0.090 |
Why?
|
| Internet | 1 | 2014 | 458 | 0.090 |
Why?
|
| Adult | 5 | 2019 | 15746 | 0.090 |
Why?
|
| Substantia Nigra | 1 | 2009 | 15 | 0.080 |
Why?
|
| HIV-1 | 1 | 2014 | 707 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2013 | 446 | 0.080 |
Why?
|
| Aphasia | 1 | 2009 | 42 | 0.080 |
Why?
|
| Lung | 1 | 2014 | 827 | 0.080 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2008 | 3 | 0.080 |
Why?
|
| Neural Pathways | 1 | 2009 | 97 | 0.080 |
Why?
|
| Temporal Lobe | 1 | 2009 | 44 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2008 | 23 | 0.080 |
Why?
|
| Apolipoprotein E4 | 1 | 2009 | 35 | 0.080 |
Why?
|
| Basal Ganglia | 1 | 2008 | 30 | 0.080 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 18 | 0.080 |
Why?
|
| Corpus Striatum | 1 | 2009 | 96 | 0.080 |
Why?
|
| Tauopathies | 1 | 2008 | 15 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 1 | 2010 | 189 | 0.080 |
Why?
|
| tau Proteins | 1 | 2008 | 104 | 0.070 |
Why?
|
| California | 2 | 2019 | 160 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 61 | 0.070 |
Why?
|
| United States | 4 | 2023 | 7495 | 0.070 |
Why?
|
| Cellular Senescence | 1 | 2008 | 103 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2006 | 25 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 162 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2008 | 461 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 281 | 0.060 |
Why?
|
| Interviews as Topic | 2 | 2019 | 486 | 0.060 |
Why?
|
| Hippocampus | 2 | 2020 | 238 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2003 | 5 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 963 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 31 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 630 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2022 | 30 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 78 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2022 | 62 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 4321 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2022 | 98 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2006 | 710 | 0.050 |
Why?
|
| Learning | 1 | 2023 | 171 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 204 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2023 | 275 | 0.050 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Emotions | 1 | 2023 | 217 | 0.040 |
Why?
|
| Pyramidal Cells | 1 | 2020 | 26 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 339 | 0.040 |
Why?
|
| San Francisco | 1 | 2019 | 8 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 193 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2019 | 8 | 0.040 |
Why?
|
| Lewy Body Disease | 1 | 2019 | 7 | 0.040 |
Why?
|
| Age Factors | 2 | 2014 | 1518 | 0.040 |
Why?
|
| Atrophy | 2 | 2009 | 64 | 0.040 |
Why?
|
| Consumer Behavior | 1 | 2019 | 35 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 644 | 0.040 |
Why?
|
| Amphetamine | 2 | 2009 | 11 | 0.040 |
Why?
|
| Dopamine Agonists | 2 | 2009 | 20 | 0.040 |
Why?
|
| Benzazepines | 2 | 2009 | 21 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 530 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 462 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 287 | 0.040 |
Why?
|
| Pharmacists | 1 | 2019 | 123 | 0.040 |
Why?
|
| Depression | 1 | 2024 | 857 | 0.040 |
Why?
|
| Focus Groups | 1 | 2019 | 291 | 0.040 |
Why?
|
| Iowa | 1 | 2017 | 20 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2000 | 1221 | 0.030 |
Why?
|
| Smartphone | 1 | 2017 | 61 | 0.030 |
Why?
|
| Wearable Electronic Devices | 1 | 2017 | 63 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 1907 | 0.030 |
Why?
|
| Pregnancy | 1 | 2023 | 2352 | 0.030 |
Why?
|
| Medicaid | 1 | 2019 | 335 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2017 | 130 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 446 | 0.030 |
Why?
|
| Procaterol | 1 | 2014 | 1 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 111 | 0.030 |
Why?
|
| Caprylates | 1 | 2014 | 12 | 0.030 |
Why?
|
| Protein Kinase C-alpha | 1 | 2014 | 16 | 0.030 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2014 | 19 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 542 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 515 | 0.030 |
Why?
|
| Models, Animal | 1 | 2014 | 220 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2000 | 764 | 0.030 |
Why?
|
| Motor Skills | 1 | 2013 | 58 | 0.030 |
Why?
|
| Executive Function | 1 | 2013 | 62 | 0.030 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2012 | 10 | 0.030 |
Why?
|
| Cilia | 1 | 2014 | 156 | 0.030 |
Why?
|
| Valine | 1 | 2012 | 30 | 0.030 |
Why?
|
| Memory | 1 | 2013 | 116 | 0.030 |
Why?
|
| Methionine | 1 | 2012 | 56 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 199 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 112 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 375 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2013 | 275 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2589 | 0.020 |
Why?
|
| Alleles | 1 | 2012 | 425 | 0.020 |
Why?
|
| Frontotemporal Dementia | 1 | 2012 | 126 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 919 | 0.020 |
Why?
|
| Grooming | 1 | 2009 | 4 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 2009 | 9 | 0.020 |
Why?
|
| Autoradiography | 1 | 2009 | 53 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 173 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2009 | 22 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2009 | 89 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2013 | 479 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 172 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2009 | 29 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 171 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 131 | 0.020 |
Why?
|
| Haplotypes | 1 | 2008 | 117 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2008 | 82 | 0.020 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2008 | 25 | 0.020 |
Why?
|
| Interleukins | 1 | 2008 | 77 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 55 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2009 | 230 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2008 | 82 | 0.020 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2006 | 7 | 0.020 |
Why?
|
| Calbindins | 1 | 2006 | 10 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2008 | 194 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 36 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 454 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 525 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 85 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2008 | 309 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 230 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 2465 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2009 | 837 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 161 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2009 | 1061 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 576 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2006 | 254 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 677 | 0.020 |
Why?
|
| Cell Survival | 1 | 2006 | 553 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 846 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 1565 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 609 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2034 | 0.010 |
Why?
|
| X Chromosome | 1 | 2003 | 44 | 0.010 |
Why?
|
| Fasting | 1 | 2003 | 51 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 84 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 3095 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 2427 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 673 | 0.010 |
Why?
|